These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6571787

  • 1. Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate.
    Inati A, Sallan SE, Cassady JR, Hitchcock-Bryan S, Clavell LA, Belli JA, Sollee N.
    Blood; 1983 Feb; 61(2):297-303. PubMed ID: 6571787
    [Abstract] [Full Text] [Related]

  • 2. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia.
    Muriel FS, Svarch E, Pavlovsky S, Eppinger-Helft M, Braier J, Vergara B, Garay G, Kvicala R, Divito JM, Failace R, Dibar E, Jimenez E.
    Blood; 1983 Aug; 62(2):241-50. PubMed ID: 6575836
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic treatment of the central nervous system in acute lymphoblastic leukemia. CT findings in 45 children off therapy.
    Scotti G, Bracchi M, Masera G, Auriti L, De Grandi C, Uderzo C.
    Ital J Neurol Sci; 1981 Dec; 2(4):361-5. PubMed ID: 6949881
    [Abstract] [Full Text] [Related]

  • 4. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 5. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
    Bleyer WA, Coccia PF, Sather HN, Level C, Lukens J, Niebrugge DJ, Siegel S, Littman PS, Leikin SL, Miller DR.
    J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
    [Abstract] [Full Text] [Related]

  • 6. Studies on the assessment of neurotoxicity in children with acute lymphoblastic leukemia.
    Muchi H, Satoh T, Yamamoto K, Karube T, Miyao M.
    Cancer; 1987 Mar 01; 59(5):891-5. PubMed ID: 3469009
    [Abstract] [Full Text] [Related]

  • 7. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
    Haghbin M, Tan CT, Clarkson BD, Miké V, Burchenal JH, Murphy ML.
    Cancer Res; 1975 Mar 01; 35(3):807-11. PubMed ID: 1054287
    [Abstract] [Full Text] [Related]

  • 8. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia.
    Rowland JH, Glidewell OJ, Sibley RF, Holland JC, Tull R, Berman A, Brecher ML, Harris M, Glicksman AS, Forman E.
    J Clin Oncol; 1984 Dec 01; 2(12):1327-35. PubMed ID: 6595350
    [Abstract] [Full Text] [Related]

  • 9. Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis.
    Brecher ML, Berger P, Freeman AI, Krischer J, Boyett J, Glicksman AS, Foreman E, Harris M, Jones B, Cohen ME.
    Cancer; 1985 Nov 15; 56(10):2430-3. PubMed ID: 3862463
    [Abstract] [Full Text] [Related]

  • 10. Central nervous system leukemia in children with acute nonlymphoblastic leukemia.
    Pui CH, Dahl GV, Kalwinsky DK, Look AT, Mirro J, Dodge RK, Simone JV.
    Blood; 1985 Nov 15; 66(5):1062-7. PubMed ID: 3840394
    [Abstract] [Full Text] [Related]

  • 11. CNS prophylaxis using a triple intrathecal drug therapy without cranial irradiation in acute lymphoblastic leukaemia.
    Asfour I, Misset JL, Mathe G, Sabbour MS.
    Int J Clin Pharmacol Res; 1988 Nov 15; 8(1):47-54. PubMed ID: 3163327
    [Abstract] [Full Text] [Related]

  • 12. Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
    Gelber RD, Sallan SE, Cohen HJ, Donnelly M, Dalton V, Tobia F, Clavell LA, Tarbell NJ.
    Cancer; 1993 Jul 01; 72(1):261-70. PubMed ID: 8508416
    [Abstract] [Full Text] [Related]

  • 13. Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study.
    Land VJ, Thomas PR, Boyett JM, Glicksman AS, Culbert S, Castleberry RP, Berry DH, Vats T, Humphrey GB.
    Cancer; 1985 Jul 01; 56(1):81-7. PubMed ID: 3859359
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and toxicity of preventive treatment with cranial irradiation and intrathecal methotrexate on the central nervous system in childhood lymphoblastic leukemia].
    Ortega JJ, Javier G, Montagut JM.
    Sangre (Barc); 1983 Jul 01; 28(1):24-38. PubMed ID: 6575484
    [No Abstract] [Full Text] [Related]

  • 15. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
    Pinkerton CR, Chessells JM.
    Br J Haematol; 1984 Aug 01; 57(4):553-61. PubMed ID: 6589013
    [Abstract] [Full Text] [Related]

  • 16. Absence of white matter changes on magnetic resonance imaging in children treated with CNS prophylaxis therapy for leukemia.
    Kramer JH, Norman D, Brant-Zawadzki M, Ablin A, Moore IM.
    Cancer; 1988 Mar 01; 61(5):928-30. PubMed ID: 3422180
    [Abstract] [Full Text] [Related]

  • 17. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation.
    Mulhern RK, Fairclough D, Ochs J.
    J Clin Oncol; 1991 Aug 01; 9(8):1348-56. PubMed ID: 2072138
    [Abstract] [Full Text] [Related]

  • 18. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children.
    Freeman AI, Weinberg V, Brecher ML, Jones B, Glicksman AS, Sinks LF, Weil M, Pleuss H, Hananian J, Burgert EO, Gilchrist GS, Necheles T, Harris M, Kung F, Patterson RB, Maurer H, Leventhal B, Chevalier L, Forman E, Holland JF.
    N Engl J Med; 1983 Mar 03; 308(9):477-84. PubMed ID: 6571946
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia.
    Ochs JJ, Rivera G, Aur RJ, Hustu HO, Berg R, Simone JV.
    J Clin Oncol; 1985 May 03; 3(5):622-6. PubMed ID: 3858436
    [Abstract] [Full Text] [Related]

  • 20. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
    Sancho JM, Morgades M, Arranz R, Fernández-Abellán P, Deben G, Alonso N, Blanes M, Rodríguez MJ, Nicolás C, Sánchez E, Fernández de Sevilla A, Conde E, Ribera JM, QUIT Study (PETHEMA, GELTAMO and GOTEL Groups).
    Med Clin (Barc); 2008 Oct 04; 131(11):401-5. PubMed ID: 18928719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.